ERITROPOETINA HUMANA RECOMBINANTE PDFERITROPOETINA HUMANA RECOMBINANTE PDF

Observou-se um caso de resistência à eritropoetina recombinante humana causada por Ectasia Vascular Antral Gástrica em uma mulher de 40 anos de idade. Abstract. DAL MASO, Rosina Conceição Graçaplena et al. Sex hormones in women on dialysis. Rev. Assoc. Med. Bras. [online]. , vol, n.4, pp . 22 out. Observou-se um caso de resistência à eritropoetina recombinante humana causada por Ectasia Vascular Antral. Gástrica em uma mulher de.

Author: Malakinos Mulabar
Country: Sudan
Language: English (Spanish)
Genre: Environment
Published (Last): 25 December 2010
Pages: 267
PDF File Size: 1.16 Mb
ePub File Size: 17.75 Mb
ISBN: 908-3-60820-691-7
Downloads: 17538
Price: Free* [*Free Regsitration Required]
Uploader: Kajora

Bregman R, Pecoits-Filho R.

Regulação da produção da eritropoietina e perspectivas terapêuticas na anemia

Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response. In hypoxic conditions, hydroxylation is inhibited and HIF signalling is activated. Brain protection by erythropoietin: During fetal life, EPO is produced by the liver. The main effort in developing these treatments is to achieve other routes of administration, more convenient for the patient, such as oral therapy, not disregarding an easier production, storage and frequency of administration.

Since then, several ESAs have appeared, characterized by lower administration frequency and better stabilization of haemoglobin concentration. The hemojuvelin binds competitively to the BMP, which prevents the signalling of its receptor and suppresses hepcidin production Every procedure in this situation should be carefully considered since surgical treatment typically involves gastric antrectomy, which, although effective are associated with significant morbidity and mortality, however, has an extremely limited role.

A conserved family of prolylhydroxylases that modify HIF. Cell Signal ;23 The etiology of GAVE syndrome remains unknown and has been associated with several disease states, including autoimmune disease e.

Erythropoietin blocks tumour cells apoptosis and potentiates angiogenesis, with increased tumour growth, metastases and reduction of the radiotherapy response Am J Pathol ; 4: Clinical Queries Nephrology ;1 3: Erythropoietin resistance in end-stage renal disease patient with gastric antral vascular ectasia. Biochem Biophys Res Commun ; 2: Several HIF stabilizers compounds have been studied.

  JAN AXELSON USB COMPLETE PDF

This inflammatory status leads to an increase in hepcidin release by the liver, with consequent serum ferritin increase and restriction on iron availability for erythropoiesis In spite of this huge advance, the first recombinant human erythropoietin has a relatively short half-life and needs to be administered two to three times per week. Jumana were divided into: The aim of this study was to evaluate the efficacy of rHuEPO in hemodialysis patients through assessment and recomblnante of haematological parameters erythrocyte line red blood cells, hematocrit and hemoglobinand biochemical iron and ferritin.

In this patient some factors were discarded such as autoimmune disease, coagulopathy, evident inflammation, vitamin deficiency, hemolysis, liver or heart disease by physical examination and laboratory tests. Furthermore, renal failure itself contributes to inflammation with an increase in advanced glycation end products AGEa reduction in plasma antioxidant activity and loss of antioxidants such as zinc, selenium and vitamins C and E.

Oral administration of K inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease. We observed gastrointestinal blood loss by rectal examination that was positive for melena and the presence of occult blood in the stool in this patient.

Relevant Facts

This work is licensed under a Creative Commons Attribution 4. Hypoxic regulation of erythropoiesis and iron metabolism.

It is eritropoetinw small peptide consisting of 25 amino acids, mainly produced by hepatocytes, whose transcription is sensitive to iron and oxygen.

Since iron availability is a limiting factor and its supplementation is usually necessary to ensure an adequate response to EPO, combination of different classes of agents can be an approach to equate. This patient required blood transfusion for acute blood loss.

Fung E, Nemeth E. The EPO gene activation in renal cells depends of microenvironmental signals and is not constitutively expressed, a possible reason why an adequate renal EPO-producing cell line is not available.

  KAOSS PAD 3 MANUAL PDF

As a result, it has largely as the first-line treatment for GAVE.

Sign in to the Lens

The EPO production in the kidney and liver stimulates erythropoiesis and an additional need for iron that leads to an increase in intestinal iron absorption and iron binding capacity, as well as an increase in iron release from body iron stores. The patient was transferred to the intensive care unit for hemodynamic instability and required 4 units of packed red blood cells RBC transfusions to treat anemia and crystalloid solution 2.

Manipulation of the hepcidin pathway for therapeutic purposes.

Watermelon stomach – antral region of the stomach with dilated vessels with signs of active bleeding. Due to its simple structure and ability to recognize and bind to various organic compounds, they are a good class of therapeutic proteins for specific blocks.

Escorcio, Carla Solange de Melo Published: Fibromuscular proliferation and capillary ectasia with microvascular thrombosis of the lamina propria form the histological hallmark of GAVE.

IL-6 inhibition and infection: Similar Items Eritropoetina humana recombinante na anemia de prematuridade: Am J Kidney Dis ;38 4: Best Pract Res Clin Anaesthesiol ;27 1: Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels. N Engl J Med ; 4: The same parameters were evaluated for the group that did not rHuEPO in this, there was no statistically significant change. For this proposition, we evaluated two distinct groups, one test group, with 77 patients who made use of rHuEPO for three weeks, and a second control group, with 38 patients who did not use this treatment, totaling people.

JAK2 activation also originates multiple binding sites for intracellular signalling proteins with src homology 2 SH2 domains 1.